Why Did ATNF Plunge 27.85% After 80.24% Surge?

On August 14, 2025, 180 Life Sciences Corp. (ATNF) experienced a significant drop of 27.85% in pre-market trading, marking a notable shift in investor sentiment towards the biotech company.

Recent developments have highlighted several key factors that could be influencing the stock's performance. On August 12, 2025, ATNF's stock price surged by 80.24%, driven by significant changes within the company. One of the most impactful events was the rebranding of 180 Life Sciences to ETHZilla and the acquisition of $350 million worth of Ethereum, which has led to a remarkable increase in the share price of over 1500% since the company began its cryptocurrency investments.

Additionally, the company's stock has shown impressive year-to-date returns, with a trailing total return of 487.91% as of August 13, 2025. This performance has outpaced the benchmark S&P 500, indicating strong investor confidence in the company's strategic moves and future prospects.

Despite these positive developments, the recent pre-market drop suggests that investors may be reassessing the company's valuation and future growth potential. The significant volatility in ATNF's stock price reflects the high-risk, high-reward nature of investing in biotech and cryptocurrency-related companies. As 180 Life Sciences continues to navigate its new strategic direction, investors will be closely monitoring the company's performance and any further developments that could impact its stock price.